The tumor-promoting effect of IL-6 largely depends upon STAT3 activation; IL-6-deficient mice have reduced tumor growth and have abrogated STAT3 activation, suggesting the importance of IL-6 and STAT3 signaling in promoting colorectal tumorigenesis. The gene discussed is STAT3; the disease is neoplasm.